Literature DB >> 28696685

Modeling Sequence-Dependent Peptide Fluctuations in Immunologic Recognition.

Cory M Ayres1, Timothy P Riley1, Steven A Corcelli1, Brian M Baker1.   

Abstract

In cellular immunity, T cells recognize peptide antigens bound and presented by major histocompatibility complex (MHC) proteins. The motions of peptides bound to MHC proteins play a significant role in determining immunogenicity. However, existing approaches for investigating peptide/MHC motional dynamics are challenging or of low throughput, hindering the development of algorithms for predicting immunogenicity from large databases, such as those of tumor or genetically unstable viral genomes. We addressed this by performing extensive molecular dynamics simulations on a large structural database of peptides bound to the most commonly expressed human class-I MHC protein, HLA-A*0201. The simulations reproduced experimental indicators of motion and were used to generate simple models for predicting site-specific, rapid motions of bound peptides through differences in their sequence and chemical composition alone. The models can easily be applied on their own or incorporated into immunogenicity prediction algorithms. Beyond their predictive power, the models provide insight into how amino acid substitutions can influence peptide and protein motions and how dynamic information is communicated across peptides. They also indicate a link between peptide rigidity and hydrophobicity, two features known to be important in influencing cellular immune responses.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28696685      PMCID: PMC5573614          DOI: 10.1021/acs.jcim.7b00118

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  32 in total

Review 1.  Major histocompatibility complex class I binding predictions as a tool in epitope discovery.

Authors:  Claus Lundegaard; Ole Lund; Søren Buus; Morten Nielsen
Journal:  Immunology       Date:  2010-05-26       Impact factor: 7.397

2.  Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald.

Authors:  Romelia Salomon-Ferrer; Andreas W Götz; Duncan Poole; Scott Le Grand; Ross C Walker
Journal:  J Chem Theory Comput       Date:  2013-08-20       Impact factor: 6.006

3.  y-Randomization and its variants in QSPR/QSAR.

Authors:  Christoph Rücker; Gerta Rücker; Markus Meringer
Journal:  J Chem Inf Model       Date:  2007-09-20       Impact factor: 4.956

4.  Peptide modulation of class I major histocompatibility complex protein molecular flexibility and the implications for immune recognition.

Authors:  William F Hawse; Brian E Gloor; Cory M Ayres; Kevin Kho; Elizabeth Nuter; Brian M Baker
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

5.  TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes.

Authors:  Diego Chowell; Sri Krishna; Pablo D Becker; Clément Cocita; Jack Shu; Xuefang Tan; Philip D Greenberg; Linda S Klavinskis; Joseph N Blattman; Karen S Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

6.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

7.  Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition.

Authors:  Oleg Y Borbulevych; Francis K Insaidoo; Tiffany K Baxter; Daniel J Powell; Laura A Johnson; Nicholas P Restifo; Brian M Baker
Journal:  J Mol Biol       Date:  2007-07-26       Impact factor: 5.469

8.  The IMGT/HLA database.

Authors:  James Robinson; Kavita Mistry; Hamish McWilliam; Rodrigo Lopez; Peter Parham; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2010-11-11       Impact factor: 16.971

9.  Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition.

Authors:  David K Cole; Emily S J Edwards; Katherine K Wynn; Mathew Clement; John J Miles; Kristin Ladell; Julia Ekeruche; Emma Gostick; Katherine J Adams; Ania Skowera; Mark Peakman; Linda Wooldridge; David A Price; Andrew K Sewell
Journal:  J Immunol       Date:  2010-07-16       Impact factor: 5.422

10.  Purposeful selection of variables in logistic regression.

Authors:  Zoran Bursac; C Heath Gauss; David Keith Williams; David W Hosmer
Journal:  Source Code Biol Med       Date:  2008-12-16
View more
  5 in total

1.  Markov state modeling reveals alternative unbinding pathways for peptide-MHC complexes.

Authors:  Jayvee R Abella; Dinler Antunes; Kyle Jackson; Gregory Lizée; Cecilia Clementi; Lydia E Kavraki
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-12       Impact factor: 11.205

2.  Structural dissimilarity from self drives neoepitope escape from immune tolerance.

Authors:  Jason R Devlin; Jesus A Alonso; Cory M Ayres; Grant L J Keller; Sara Bobisse; Craig W Vander Kooi; George Coukos; David Gfeller; Alexandre Harari; Brian M Baker
Journal:  Nat Chem Biol       Date:  2020-08-17       Impact factor: 15.040

3.  Structurally silent peptide anchor modifications allosterically modulate T cell recognition in a receptor-dependent manner.

Authors:  Angela R Smith; Jesus A Alonso; Cory M Ayres; Nishant K Singh; Lance M Hellman; Brian M Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-26       Impact factor: 12.779

4.  Dynamically Driven Allostery in MHC Proteins: Peptide-Dependent Tuning of Class I MHC Global Flexibility.

Authors:  Cory M Ayres; Esam T Abualrous; Alistair Bailey; Christian Abraham; Lance M Hellman; Steven A Corcelli; Frank Noé; Tim Elliott; Brian M Baker
Journal:  Front Immunol       Date:  2019-05-03       Impact factor: 7.561

5.  Dynamic allostery controls the peptide sensitivity of the Ly49C natural killer receptor.

Authors:  Jiaqi Ma; Cory M Ayres; Lance M Hellman; Jason R Devlin; Brian M Baker
Journal:  J Biol Chem       Date:  2021-04-20       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.